1. Home
  2. RRGB vs ATOS Comparison

RRGB vs ATOS Comparison

Compare RRGB & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Red Robin Gourmet Burgers Inc.

RRGB

Red Robin Gourmet Burgers Inc.

HOLD

Current Price

$4.00

Market Cap

74.4M

ML Signal

HOLD

Logo Atossa Therapeutics Inc.

ATOS

Atossa Therapeutics Inc.

HOLD

Current Price

$0.64

Market Cap

83.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RRGB
ATOS
Founded
1969
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
74.4M
83.3M
IPO Year
2002
2012

Fundamental Metrics

Financial Performance
Metric
RRGB
ATOS
Price
$4.00
$0.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$9.67
$6.33
AVG Volume (30 Days)
162.9K
1.3M
Earning Date
02-25-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,226,409,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.50
$0.55
52 Week High
$7.89
$1.29

Technical Indicators

Market Signals
Indicator
RRGB
ATOS
Relative Strength Index (RSI) 41.42 40.03
Support Level $3.98 $0.62
Resistance Level $4.18 $0.70
Average True Range (ATR) 0.16 0.04
MACD 0.01 0.00
Stochastic Oscillator 10.17 52.07

Price Performance

Historical Comparison
RRGB
ATOS

About RRGB Red Robin Gourmet Burgers Inc.

Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. Its brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue. The company has one operating and one reportable segment: restaurants.

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

Share on Social Networks: